Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate - PubMed
Comparative Study
Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate
Anna L Schwartz et al. Oncol Nurs Forum. 2002 Aug.
Abstract
Purpose/objectives: To examine the effect of exercise and methylphenidate on fatigue, functional ability, and cognitive function in patients with melanoma.
Design: Pilot study with comparison to historic controls.
Setting: University-based cancer center.
Sample: 12 patients with melanoma entered and completed the study. The mean age was 44 years.
Method: Eligible patients were recruited before their first dose of interferon-a (IFN-a). Patients were instructed to take 20 mg sustained-release methylphenidate every morning and follow an aerobic exercise program four days a week for 15-30 minutes. Measures included a 12-minute walk, the Schwartz Cancer Fatigue Scale, Trail Maker Forms A and B, Medical Outcomes Study 36 Short Form, body weight, and daily logs. Fatigue scores were compared to usual care historical controls with melanoma receiving only IFN-a.
Main research variables: Fatigue, functional ability, and cognitive function.
Findings: 66% adhered to exercise and methylphenidate; all adhered to exercise. Fatigue was lower for the exercise and methylphenidate group than historic controls. Functional ability increased 6% for all patients and 9% for the exercise and methylphenidate group. Cognitive function was stable for the exercise and methylphenidate group. The exercise-only group showed marked cognitive slowing.
Conclusion: The combination of aerobic exercise and methylphenidate may have a positive effect on fatigue, cognitive function, and functional ability. A larger sample size and randomized trial is needed to more rigorously evaluate the results of exercise and methylphenidate alone or in combination.
Implications for nursing: Although further study is needed, a combination of exercise and methylphenidate may be a practical intervention for patients receiving IFN-a for melanoma.
Similar articles
-
Butler JM Jr, Case LD, Atkins J, Frizzell B, Sanders G, Griffin P, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG. Butler JM Jr, et al. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1496-501. doi: 10.1016/j.ijrobp.2007.05.076. Epub 2007 Sep 14. Int J Radiat Oncol Biol Phys. 2007. PMID: 17869448 Clinical Trial.
-
Fu MR, Anderson CM, McDaniel R, Armer J. Fu MR, et al. Oncol Nurs Forum. 2002 Jul;29(6):961-6. doi: 10.1188/02.ONF.961-966. Oncol Nurs Forum. 2002. PMID: 12096293
-
Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL. Bruera E, et al. J Clin Oncol. 2006 May 1;24(13):2073-8. doi: 10.1200/JCO.2005.02.8506. J Clin Oncol. 2006. PMID: 16648508 Clinical Trial.
-
Evidence-based practice for fatigue management in adults with cancer: exercise as an intervention.
Stricker CT, Drake D, Hoyer KA, Mock V. Stricker CT, et al. Oncol Nurs Forum. 2004 Sep 17;31(5):963-76. doi: 10.1188/04.ONF.963-976. Print 2004 Sep. Oncol Nurs Forum. 2004. PMID: 15378097 Review.
-
Valdizán Usón JR, Idiazábal Alecha MA. Valdizán Usón JR, et al. Expert Rev Neurother. 2008 Jun;8(6):917-27. doi: 10.1586/14737175.8.6.917. Expert Rev Neurother. 2008. PMID: 18505357 Review.
Cited by
-
Psychiatric clearance for patients started on interferon-alpha-based therapies.
Lotrich FE. Lotrich FE. Am J Psychiatry. 2013 Jun;170(6):592-7. doi: 10.1176/appi.ajp.2013.12121572. Am J Psychiatry. 2013. PMID: 23732965 Free PMC article. No abstract available.
-
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.
Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Miller AH, et al. J Clin Oncol. 2008 Feb 20;26(6):971-82. doi: 10.1200/JCO.2007.10.7805. J Clin Oncol. 2008. PMID: 18281672 Free PMC article. Review.
-
Cueva JF, Calvo M, Anido U, León L, Gallardo E, Areses C, Bernárdez B, Gayoso L, García J, Jesús Lamas M, Curiel T, Vázquez F, Candamio S, Vidal Y, Javier Barón F, López R. Cueva JF, et al. Invest New Drugs. 2012 Apr;30(2):688-94. doi: 10.1007/s10637-010-9539-7. Epub 2010 Sep 16. Invest New Drugs. 2012. PMID: 20844926 Clinical Trial.
-
Inflammation at the intersection of behavior and somatic symptoms.
Irwin MR. Irwin MR. Psychiatr Clin North Am. 2011 Sep;34(3):605-20. doi: 10.1016/j.psc.2011.05.005. Psychiatr Clin North Am. 2011. PMID: 21889682 Free PMC article. Review. No abstract available.
-
The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse.
Dougherty JP, Springer DA, Gershengorn MC. Dougherty JP, et al. J Vis Exp. 2016 May 31;(111):54052. doi: 10.3791/54052. J Vis Exp. 2016. PMID: 27286034 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical